Riskpilot← Back to searchSign inGet full accessLOTUS KLINIKK AS
ASActiveOrg 998406773Torget 2, 7240 HitraOther human health activities n.e.c. · NACE 8699Est. 20123 employees
Revenue 2024
NOK 1,9M
-7% vs 2023
EBITDA margin
-4.2%
-395% vs 2023
Equity ratio
24.7%
Financial strength
Net profit 2024
NOK -113K
-53% vs 2023
| Revenue | NOK 1,9M | -7% |
| EBITDA | NOK -80K | -395% |
| Net profit | NOK -113K | -53% |
| Total assets | NOK 696K | -16% |
| Equity | NOK 172K | -40% |
| Employees | 3 | — |
Legal name
LOTUS KLINIKK AS
Org number
998406773
Legal form
Aksjeselskap
NACE code
8699 · Other human health activities n.e.c.
Founded
22. mai 2012
Share capital
NOK 100 000
Employees
3 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Terapeutisk massasje og hudpleie, samt tilhørende aktiviteter. Selskapet kan delta i andre selskaper.
Address
Torget 2, 7240 Hitra
Phone
+4747290221
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 2 694 | 2 785 | 2 136 | 2 041 | 1 893 |
| Staff expenses | −1 380 | −1 477 | −844 | −777 | −761 |
| EBITDA | −24 | −68 | 166 | −16 | −80 |
| Depreciation & amort. | −134 | −116 | −97 | −79 | −67 |
| EBIT | −158 | −184 | 69 | −95 | −146 |
| Net financials | −11 | −10 | −5 | 2 | 2 |
| Profit before tax | −169 | −194 | 64 | −94 | −144 |
| Tax | −36 | −41 | 14 | −20 | −31 |
| Net profit | −133 | −153 | 49 | −74 | −113 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 335 | 1 072 | 951 | 829 | 696 |
| Equity | 462 | 310 | 359 | 285 | 172 |
| Long-term debt | 257 | 147 | 65 | 0 | 0 |
| Short-term debt | 616 | 616 | 527 | 544 | 524 |
| Total debt | 873 | 763 | 592 | 544 | 524 |
EBITDA margin
-4.2%
This company
15.8%
Market median
-127% vs market
20202024
Equity ratio
24.7%
This company
38.2%
Market median
-35% vs market
20202024
Return on equity
-65.6%
This company
18.4%
Market median
-457% vs market
20202024
Net profit margin
-6.0%
This company
8.1%
Market median
-174% vs market
20202024
Asset turnover
2.72×
This company
1.12×
Market median
+143% vs market
20202024
Debt / equity
3.05×
This company
0.62×
Market median
-392% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
DJ Chief Executive Officer | Chief Executive Officer | 2012 |
KP Deputy Member | Deputy Member | 2012 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2012 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of LOTUS KLINIKK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Danijela Jeremic | Chief Executive Officer | 0 companies |
| Karl Petter Nyvold | Deputy Member | 0 companies |
| Arnold Andreas Jobotn | Chairman | 0 companies |